Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
"Targeting Transforming Growth Factor-β (TGF-β) in Cancer and Non-Neoplastic Diseases"
written by Michael Nacif, Olfat Shaker,
published by Journal of Cancer Therapy, Vol.5 No.7, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Eugenol and capsaicin exhibit anti-metastatic activity via modulating TGF-β signaling in gastric carcinoma
2020
[2] Directed Blocking of TGF-β Receptor I Binding Site Using Tailored Peptide Segments to Inhibit its Signaling Pathway
2020
[3] Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS‐986260, mitigates class‐based cardiovascular toxicity in dogs but not rats
2020
[4] β-Peltoboykinolic Acid from Astilbe rubra Attenuates TGF-β1-Induced Epithelial-to-Mesenchymal Transitions in Lung Alveolar Epithelial Cells
2019
[5] Receptors for Targeting Growth Factors for Treatment of Cancers
2019
[6] Increased transforming growth factor-β and interleukin-17 transcripts in peripheral blood of breast cancer patients with different clinical stages
2018
[7] Biemamides A–E, Inhibitors of the TGF-β Pathway That Block the Epithelial to Mesenchymal Transition
Organic Letters, 2018
[8] Increased Transforming Growth Factor‑β and Interleukin‑17 Transcripts in Peripheral Blood of Breast Cancer Patients with Different Clinical Stages
2018
[9] Study the effects of Dibromotyrosine Derivative in TGF-β responsiveness
2017
[10] A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF‐β Responsiveness by Inhibiting TGF‐β Type I Receptor Serine/Threonine …
Journal of Cellular Biochemistry, 2016
[11] Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of Iran
Iranian Journal of Cancer Prevention, 2016
[12] P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
Cancer Letters, 2016
[13] La via del TGF-β com a diana terapèutica per inhibir la progressió tumoral i la metàstasi
2016
[14] A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF‐β Responsiveness by Inhibiting TGF‐β Type I Receptor Serine/Threonine …
Journal of Cellular Biochemistry, 2016
[15] Characterization of cellular and molecular responses of human glioblastoma to Transforming Growth Factor-β signalling pathway inhibition
2016
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.
Top